Daiichi-Sankyo (Japan)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
5.5K
Total Open
Publications
2.7K
Total
Citations
177K
Open Access
Percentage
49%
Total
Publications
5.5K
Total Open
Publications
2.7K
Total
Citations
177K
Breakdown
Publisher Open
27%
Both
19%
Other Platform Open
3%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
689
Hybrid 35%
852
No Guarantees 37%
913
Other Platform Open
Domain 80%
973
Institution 20%
237
Other Internet 18%
220
Public 3%
38
Preprint 0%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 977 |
DOI | Other Internet | 181 |
DANS - Data Archiving and Networked Services | Institution | 60 |
Europe PMC | Domain | 54 |
Unknown Repository | Other Internet | 48 |
Figshare | Public | 36 |
Elsevier - Scopus | Institution | 26 |
universiteitleiden.nl OAI-PMH Repository | Institution | 15 |
DASH - Digital Access to Scholarship at Harvard | Institution | 12 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 11 |